American Conference Institute’s Rx Drug Pricing & Rebate Fundamentals

FDA and Healthcare partner Scott Memmott is joining the American Conference Institute’s Rx Drug Pricing & Rebate Fundamentals webinar series on November 6. This series covers everything a pharmaceutical manufacturer needs to know about how Medicare, Medicaid, 340b, the One Big Beautiful Bill Act, and other programs affecting drug pricing.

Scott’s presentation will cover regulatory considerations around Prescription Drug Affordability Boards (PDABs). These boards play a critical role in determining upper payment limits for new medications and can subject manufacturers to drug affordability reviews. Scott will share his insights on how to handle PDAB inquiries and their priorities in the future.